These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 33612044)

  • 41. The selection of antigens for the diagnosis, prognosis and evolutive study of parasitic diseases.
    Sogandares-Bernal F; Matthews JL
    Vet Parasitol; 1984 Jun; 14(3-4):185-91. PubMed ID: 6433536
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Vaccines and the regulatory arm of the immune system. An overview from the Trypanosoma cruzi infection model.
    Cabrera G; Marcipar I
    Vaccine; 2019 Jun; 37(28):3628-3637. PubMed ID: 31155420
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The role of natural selection in shaping genetic variation in a promising Chagas disease drug target: Trypanosoma cruzi trans-sialidase.
    Gallant JP; Lima-Cordón RA; Justi SA; Monroy MC; Viola T; Stevens L
    Infect Genet Evol; 2018 Aug; 62():151-159. PubMed ID: 29684709
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Coadministration of cruzipain and GM-CSF DNAs, a new immunotherapeutic vaccine against Trypanosoma cruzi infection.
    Cerny N; Sánchez Alberti A; Bivona AE; De Marzi MC; Frank FM; Cazorla SI; Malchiodi EL
    Hum Vaccin Immunother; 2016; 12(2):438-50. PubMed ID: 26312947
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Prophylactic and therapeutic DNA vaccines against Chagas disease.
    Arce-Fonseca M; Rios-Castro M; Carrillo-Sánchez Sdel C; Martínez-Cruz M; Rodríguez-Morales O
    Parasit Vectors; 2015 Feb; 8():121. PubMed ID: 25885641
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Why do we still have not a vaccine against Chagas disease?
    Camargo EP; Gazzinelli RT; Morel CM; Precioso AR
    Mem Inst Oswaldo Cruz; 2022; 117():e200314. PubMed ID: 35544856
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Trypanosoma cruzi infection from the view of CD8+ T cell immunity--an infection model for developing T cell vaccine.
    Miyahira Y
    Parasitol Int; 2008 Mar; 57(1):38-48. PubMed ID: 17728174
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Control and management of congenital Chagas disease in Europe and other non-endemic countries: current policies and practices.
    Soriano-Arandes A; Angheben A; Serre-Delcor N; Treviño-Maruri B; Gómez I Prat J; Jackson Y
    Trop Med Int Health; 2016 May; 21(5):590-6. PubMed ID: 26932338
    [TBL] [Abstract][Full Text] [Related]  

  • 49.
    Trevisan RO; Santos MM; Desidério CS; Alves LG; de Jesus Sousa T; de Castro Oliveira L; Jaiswal AK; Tiwari S; Bovi WG; de Oliveira-Silva M; Costa-Madeira JC; Castellano LRC; Silva MV; Azevedo V; Rodrigues Junior V; Oliveira CJF; de Castro Soares S
    Dis Markers; 2020; 2020():9130719. PubMed ID: 33488847
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Chagas Disease and Coumarins: A Review of Natural and Synthetic Coumarins As Anti-Trypanosoma Cruzi Agents.
    Gonçalves GA; Cerecetto H; Poser GLV; Canto RFS; Eifler-Lima VL
    Mini Rev Med Chem; 2021; 21(13):1701-1717. PubMed ID: 33372872
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Experimental Chagas disease in Balb/c mice previously vaccinated with T. rangeli. II. The innate immune response shows immunological memory: reality or fiction?
    Basso B; Marini V
    Immunobiology; 2015 Mar; 220(3):428-36. PubMed ID: 25454810
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Likely Autochthonous Transmission of Trypanosoma cruzi to Humans, South Central Texas, USA.
    Gunter SM; Murray KO; Gorchakov R; Beddard R; Rossmann SN; Montgomery SP; Rivera H; Brown EL; Aguilar D; Widman LE; Garcia MN
    Emerg Infect Dis; 2017 Mar; 23(3):500-503. PubMed ID: 28221110
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Nanomedicines against Chagas disease: an update on therapeutics, prophylaxis and diagnosis.
    Morilla MJ; Romero EL
    Nanomedicine (Lond); 2015 Feb; 10(3):465-81. PubMed ID: 25707979
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Immunotherapy of Trypanosoma cruzi infection with DNA vaccines in mice.
    Dumonteil E; Escobedo-Ortegon J; Reyes-Rodriguez N; Arjona-Torres A; Ramirez-Sierra MJ
    Infect Immun; 2004 Jan; 72(1):46-53. PubMed ID: 14688079
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Technological innovation strategies for the specific treatment of Chagas disease based on Benznidazole.
    Ferraz LRM; Alves AÉG; Nascimento DDSDS; Amariz IAE; Ferreira AS; Costa SPM; Rolim LA; Lima ÁAN; Rolim Neto PJ
    Acta Trop; 2018 Sep; 185():127-132. PubMed ID: 29452113
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Characterization and Stability of Trypanosoma cruzi 24-C4 (Tc24-C4), a Candidate Antigen for a Therapeutic Vaccine Against Chagas Disease.
    Biter AB; Weltje S; Hudspeth EM; Seid CA; McAtee CP; Chen WH; Pollet JB; Strych U; Hotez PJ; Bottazzi ME
    J Pharm Sci; 2018 May; 107(5):1468-1473. PubMed ID: 29274820
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Experimental Chagas disease. Innate immune response in Balb/c mice previously vaccinated with Trypanosoma rangeli. I. The macrophage shows immunological memory: Reality or fiction?
    Basso B; Marini V
    Immunobiology; 2014 Apr; 219(4):275-84. PubMed ID: 24321621
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Recombinant Arthrobacter β-1, 3-glucanase as a potential effector molecule for paratransgenic control of Chagas disease.
    Jose C; Klein N; Wyss S; Fieck A; Hurwitz I; Durvasula R
    Parasit Vectors; 2013 Mar; 6():65. PubMed ID: 23497594
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Chagas disease and breast-feeding.
    Norman FF; López-Vélez R
    Emerg Infect Dis; 2013 Oct; 19(10):1561-6. PubMed ID: 24050257
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Efficacy of a trans-sialidase-ISCOMATRIX subunit vaccine candidate to protect against experimental Chagas disease.
    Bontempi IA; Vicco MH; Cabrera G; Villar SR; González FB; Roggero EA; Ameloot P; Callewaert N; Pérez AR; Marcipar IS
    Vaccine; 2015 Mar; 33(10):1274-83. PubMed ID: 25625671
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.